Effect of dapagliflozin on eGFR slope in IgA nephropathy based on renal pathological assessment using image analysis software
However, it should be noted that this study has limitations, including the absence of a control group, the small data size, and its pilot study nature. Therefore, it cannot be stated unequivocally that dapagliflozin's efficacy is definitively demonstrated by Mes Fx predictive role.
Authors
- Akira Mima (ORCID: https://orcid.org/0000-0002-1250-7437)
- Takahiro Nakamoto (ORCID: https://orcid.org/0009-0006-7540-1812)
- Shinji Lee
- Keishi Matsumoto
- Yuta Saito
- Takaaki Morikawa
Institutions
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Metabolism Open
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.metop.2025.100392
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science